CollPlant Biotechnologies
CLGN
13 hedge funds and large institutions have $4.59M invested in CollPlant Biotechnologies in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
8% more funds holding
Funds holding: 12 → 13 (+1)
0.03% more ownership
Funds ownership: 1.08% → 1.11% (+0.03%)
32% less capital invested
Capital invested by funds: $6.79M → $4.59M (-$2.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Pinnacle Associates
New York
|
+$87.7K |
| 2 |
AE
AMH Equity
Great Neck,
New York
|
+$70.3K |
| 3 |
Renaissance Technologies
New York
|
+$43.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$41.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$17.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BEI
Benjamin Edwards Inc
Clayton,
Missouri
|
-$112K |
| 2 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
-$4.07K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.34K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$732 |
CLGN Hedge Fund Activity: Q4 2024 in Review
13 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q4 2024, worth a combined $4.59M — down 32% from $6.79M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CLGN positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Pinnacle Associates, adding an estimated $87.7K. The largest seller was Benjamin Edwards Inc, exiting entirely with an estimated $112K sold.
- 13 institutional investors held CollPlant Biotechnologies (CLGN) as of Q4 2024, up from 12 in Q3 2024.
- Funds reported $4.59M of CollPlant Biotechnologies stock for Q4 2024, down 32% quarter-over-quarter.
- 2 funds opened new CollPlant Biotechnologies positions in Q4 2024 and 1 closed out, a net change of +1 holder.
- The largest CollPlant Biotechnologies buyer in Q4 2024 was Pinnacle Associates, an estimated $87.7K added.
- The largest CollPlant Biotechnologies seller in Q4 2024 was Benjamin Edwards Inc, an estimated $112K sold.
Based on aggregated 13F filings for Q4 2024.